Results 251 to 260 of about 32,848 (294)
Some of the next articles are maybe not open access.

Imaging in Hyperthermic Intraperitoneal Chemotherapy.

RadioGraphics
Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery (CRS) (CRS-HIPEC) has revolutionized the management of peritoneal malignancies, pivoting from a palliative care approach to a treatment strategy tailored to improve ...
Shravya Srinivas Rao   +6 more
semanticscholar   +3 more sources

Hyperthermic Intraperitoneal Chemotherapy.

Journal of PeriAnesthesia Nursing
Alisar M. Aljundi, R. Wolfe
semanticscholar   +3 more sources

Development and Validation of Nomograms to Predict Survival in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin.

JAMA Surgery, 2023
Importance Pseudomyxoma peritoni, a rare condition characterized by mucinous ascites and peritoneal deposits, mainly originates from a ruptured mucinous appendix tumor and is considered an indolent disease but can progress and become fatal.
K. Chandrakumaran   +4 more
semanticscholar   +1 more source

Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review.

JAMA Oncology, 2021
Importance The peritoneal surface is a common site of disease in ovarian and colorectal cancer. Peritoneal metastases carry a poor prognosis, despite maximal therapeutic efforts, including surgical removal of tumor deposits and intravenous chemotherapy ...
R. V. van Stein   +3 more
semanticscholar   +1 more source

Peritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy

Surgical Clinics of North America, 2020
Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy is an aggressive, potentially curative approach used to treat locoregional disease associated with primary and secondary malignancies of the peritoneum. It involves resection of all macroscopic disease larger than 2.5 mm, followed by instillation of hyperthermic chemotherapy ...
Eric, Pletcher   +2 more
openaire   +2 more sources

Hyperthermic Intraperitoneal Chemotherapy

Advances in Anesthesia, 2005
Cancer treatment frequently requires a multimodality approach, involving surgical resection(s), radiotherapy, and chemotherapy. Advanced surgical approaches allow for the combination of two of these, offering patients intraoperative radiotherapy with surgical resection or intraoperative chemotherapy targeted and limited to a particular body region. The
Alicia M. Kowalski, Thomas B. Dougherty
openaire   +1 more source

Hyperthermic intraperitoneal chemotherapy for treating ovarian cancer

JAAPA, 2021
ABSTRACT Hyperthermic intraperitoneal chemotherapy (HIPEC) has been used for decades as a treatment for disseminated abdominal malignancies, including pseudomyxoma peritonei and peritoneal mesothelioma. HIPEC had been used to treat recurrent ovarian cancer only when curative options were lacking, but new data indicate that it may be suitable ...
Shilpa, Gajarawala   +4 more
openaire   +2 more sources

Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).

British Journal of Surgery, 2021
BACKGROUND The incidence of gastric poorly cohesive carcinoma (PCC) is increasing. The prognosis for patients with peritoneal metastases remains poor and the role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is ...
P. Bonnot   +26 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy